Skip to main content

Table 2 Change from baseline in assessed outcomes at end of the 16-week intervention

From: Motivational counselling and SMS-reminders for reduction of daily sitting time in patients with rheumatoid arthritis: a descriptive randomised controlled feasibility study

Variables

Intervention group (N = 10) Median, M(SD)

Control group (N = 9) Median, M(SD)

Difference between groups M(SD)

Daily sitting time Hours/day

−0.04,−0.30 (1.90)

0.18, 0.15 (1.43)

−0.46 (1.70)

Breaks in sitting time N/day

1.00, 1.00 (5.00)

−5.00, −3.00 (9.5)

5.00 (13.00)

Leisure time sitting Hours/day

0.00, 0.25 (1.72)

−0.50, −1.00 (2.45)

1.25 (2.01)

Physical function

0.00, −0.05 (0.12)

0.00, 0.07 (0.28)

−0.12(0.22)

Fatigue

 General fatigue

0.50, 0.40 (3.80)

1.00, 0.77 (2.54)

−0.38 (3.27)

 Physical fatigue

−3.50, −0.90 (5.57)

1.00, 0.44 (3.00)

−1.34 (4.54)

 Reduced activity

−0.50, −1.80 (4.34)

1.00, 0.88 (3.72)

−2.70 (4.06)

 Reduced motivation

1.50, 1.00 (3.23)

0.00, 0.00 (2.96)

1.00 (3.10)

 Mental fatigue

−1.50, −1.50 (4.43)

0.00, 0.00 (2.41)

−1.50 (3.62)

Pain mm

4.00, 3.00 (20.52)

2.00, 7.22 (18.20)

−4.22 (19.45)

HR-QoLa

 SF36-PCS

−7.50, −8.38 (5.50)

−20.00, −21.22 (9.47)

12.85 (7.87)

 SF36-MCS

1.50, 4.38 (8.08)

−2.00, −0.55 (7.20)

4.90 (7.63)

Self-efficacy (GSES)

0.50, 0.70 (2.58)

−1.00, −1.33 (1.87)

2.03 (2.28)

Lipids (mmol/L)

 Cholesterol (total)

−0.45, −0.66 (0.78)

0.20, 0.24 (0.38)

−0.90 (0.63)

 HDL

−0.02, −0.046 (0.15)

0.00, 0.07 (0.36)

−0.12 (0.27)

 LDL

−0.10, 0.14 (0.89)

0.10, 0.24 (0.60)

−0.10 (0.77)

 Triglycerid

−0.36, −0.43 (0.42)

0.05, 0.12 (0.32)

−0.55 (0.38)

HbA1c (mmol/mol)b

0.05, −0.26 (1.27)

0.30, 0.36 (0.24)

−0.62 (0.94)

Blood pressure (mmHg)

 Systolic

2.70, 4.71 (6.53)

1.60, 0.93 (9.37)

3.77 (8.00)

 Diastolic

0.30, −0.27 (5.10)

−2.00, −0.45 (6.70)

0.19 (5.90)

Weight (Kg)

−0.50, 0.20 (2.14)

0.70, 0.41 (1.10)

−0.21 (1.73)

Waist circumference (cm)

0.00, 8.24 (17.38)

2.00, 5.00 (8.80)

3.25 (14.00)

BMI

−0.17, 0.07 (0.72)

0.27, 1.84 (5.03)

−1.78 (3.50)

Waist-hip-ratio

−0.01, 0.04 (0.12)

0.04, 0.04 (0.03)

0.00 (0.01)

  1. aTwo participants in the intervention group did not provide answers for the SF-36 questionnaire at end of intervention
  2. bParticipants were not fasting before measurement of HbA1c
Back to article page